Just a moment, the page is loading...

SANOFI-ASY12295




A prospective, longitudinal, non-pharmacological, case-controlled study to evaluate longitudinal disease behavior and biomarker data over a 52-week    period in idiopathic pulmonary fibrosis patients
N/A
ASY12295
Not available
Idiopathic Pulmonary Fibrosis
N/A
Datasets and document are available as per Sanofi Policy and criteria
September 2019